PE20030628A1 - Compuestos destinados a reducir la ingestion excesiva de alimento - Google Patents

Compuestos destinados a reducir la ingestion excesiva de alimento

Info

Publication number
PE20030628A1
PE20030628A1 PE2002000959A PE2002000959A PE20030628A1 PE 20030628 A1 PE20030628 A1 PE 20030628A1 PE 2002000959 A PE2002000959 A PE 2002000959A PE 2002000959 A PE2002000959 A PE 2002000959A PE 20030628 A1 PE20030628 A1 PE 20030628A1
Authority
PE
Peru
Prior art keywords
reduce excessive
food ingestion
excessive food
compounds intended
refers
Prior art date
Application number
PE2002000959A
Other languages
English (en)
Inventor
Joachim Mierau
Michael Paul Pieper
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20030628A1 publication Critical patent/PE20030628A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A AGENTES AGONISTAS DE RECEPTORES DE DOPAMINA D1, D2, D3, D4 PARA LA PREPARACION DE UN MEDICAMENTO DESTINADO A LA REDUCCION DE UNA INGESTION EXCESIVA DE ALIMENTO DE PREFERENCIA PRAMIPEXOL, TALIPEXOL EN FORMA DE HIDRATOS Y SOLVATOS. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE AGENTES AGONISTAS DE DOPAMINA D1, D2, D3, D4, ANOREXICOS, INHIBIDORES DE LIPASAS, SIMPATICOMIMETICOS
PE2002000959A 2001-09-28 2002-09-27 Compuestos destinados a reducir la ingestion excesiva de alimento PE20030628A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10148233A DE10148233A1 (de) 2001-09-28 2001-09-28 Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme

Publications (1)

Publication Number Publication Date
PE20030628A1 true PE20030628A1 (es) 2003-07-15

Family

ID=7700867

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000959A PE20030628A1 (es) 2001-09-28 2002-09-27 Compuestos destinados a reducir la ingestion excesiva de alimento

Country Status (9)

Country Link
US (7) US20030087941A1 (es)
EP (1) EP1438047A2 (es)
JP (1) JP2005504110A (es)
AU (1) AU2002337135A1 (es)
CA (1) CA2461586A1 (es)
DE (1) DE10148233A1 (es)
PE (1) PE20030628A1 (es)
UY (1) UY27459A1 (es)
WO (1) WO2003028710A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
DE10312809A1 (de) * 2003-03-21 2004-09-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2005039580A1 (en) * 2003-10-16 2005-05-06 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
AU2005205882A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
AU2005205880B2 (en) * 2004-01-22 2010-06-10 Neurosearch A/S Compounds for the sustained reduction of body weight
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US7754770B2 (en) * 2005-06-27 2010-07-13 Mason Chemical Company Antimicrobial composition
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US10035932B2 (en) * 2007-09-25 2018-07-31 Aero Advanced Paint Technology, Inc. Paint replacement films, composites therefrom, and related methods
CA2622696A1 (en) * 2007-11-05 2009-05-05 Diane Mcintosh Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
WO2010030887A1 (en) 2008-09-11 2010-03-18 Catholic Healthcare West Nicotinic attenuation of cns inflammation and autoimmunity
WO2011139983A1 (en) * 2010-05-03 2011-11-10 Catholic Healthcare West Novel methods of use of tetrahydroberberine (thb)
HUE043518T2 (hu) * 2012-05-07 2019-08-28 Omeros Corp Függõség és impulzuskontroll zavarok kezelése PDE-7-inhibitorok alkalmazásával
KR102309836B1 (ko) 2013-07-18 2021-10-12 에스케이바이오팜 주식회사 비만의 치료

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8800823A (nl) * 1987-04-10 1988-11-01 Sandoz Ag Werkwijze voor het toepassen van dopamine-receptor agonisten en farmaceutische preparaten die deze agonisten bevatten.
WO1990013294A1 (en) * 1989-05-09 1990-11-15 Whitby Research, Inc. A method of reducing body weight and food intake using a dopamine d2 receptor agonist
US6004990A (en) * 1994-06-03 1999-12-21 Zebra Pharmaceuticals Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
US20010016582A1 (en) * 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
AU1305999A (en) * 1997-11-14 1999-06-07 Warner-Lambert Company (+)-ephedrine as a sympathomimetic drug
EA200300125A1 (ru) * 1998-05-15 2003-06-26 Фармация Энд Апджон Компани Применение каберголина для лечения полисистемной атрофии и прогрессирующего супрануклеарного паралича
US6312716B1 (en) * 1999-05-10 2001-11-06 Peierce Management Llc Patch and method for transdermal delivery of bupropion base
CA2324801A1 (en) * 1999-11-10 2001-05-10 Andrew Gordon Swick Use of apo b secretion/mtp inhibitors and anti-obesity agents
AU2080201A (en) * 1999-12-10 2001-06-18 University Of Cincinnati, The Treatment of addiction disorders
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme

Also Published As

Publication number Publication date
JP2005504110A (ja) 2005-02-10
US20050032812A1 (en) 2005-02-10
WO2003028710A3 (de) 2003-09-12
US20080051444A1 (en) 2008-02-28
AU2002337135A1 (en) 2003-04-14
CA2461586A1 (en) 2003-04-10
US20060223869A1 (en) 2006-10-05
DE10148233A1 (de) 2003-04-10
EP1438047A2 (de) 2004-07-21
US20080051443A1 (en) 2008-02-28
US20030087941A1 (en) 2003-05-08
UY27459A1 (es) 2003-04-30
WO2003028710A2 (de) 2003-04-10
US20060030607A1 (en) 2006-02-09
US20050032843A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
PE20030628A1 (es) Compuestos destinados a reducir la ingestion excesiva de alimento
BRPI0413363A (pt) formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
BR122018014454B8 (pt) forma cristalina sólida a do cloridrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol
WO2008024490A3 (en) Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
PE20011306A1 (es) Combinacion de un inhibidor de la recaptacion de norepinefrina y un agente antimuscarinico
WO2004089353A3 (en) Methods for treatment of parkinson's disease
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
MXPA05010476A (es) Composiciones de inhibidores selectivos de ciclooxigenasa-2 y agonistas de 5-hidroxitripamina1b/1d para el tratamiento y prevencion de migrana.
AR052038A1 (es) Composicion para el cuidado bucal que comprende un compuesto fenolico y vitaminas y derivados de vitaminas antioxidantes
AR109263A2 (es) Composición que comprende moxidectina
WO2009100441A3 (en) Depot formulations
HN2001000146A (es) Derivados de pirazol
IL162699A0 (en) Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2- selective inhibitors
WO2005115370A3 (en) Compounds and methods for treating non-inflammatory pain using pparalpha agonists
AR059160A1 (es) Composiciones detergentes
CO5680386A2 (es) Tirita para refrescar el aliento, mejorada por enzimas
CR8003A (es) Composiciones limpiadoras en la forma de una tableta
UY27610A1 (es) Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos
DOP2002000373A (es) Composiciones que contienen imidazotriazinona para administración nasal
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
TW200624119A (en) An oral liquid pharmaceutical composition of leukotriene antagonists
AU2007310767A1 (en) New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90

Legal Events

Date Code Title Description
FA Abandonment or withdrawal